Nelnet Q4 GAAP net loss $8.6M ($0.23/share) on renewable charges

NELNET INC

2023-FY EPS reported $2.45

GAAP net loss $8.6M vs net income $30.8M YoY; non-GAAP net loss $1.3M ($0.04/share).
Nelnet Renewable Energy division incurred $40.3M after-tax losses including $20.6M impairment.
Education Technology Services revenue $106.1M (+8% YoY) and net income $10.1M (+74%).
AGM net interest income fell to $35.6M from $58.5M; loan portfolio averaged $12.5B.
Operating cash flow $433M in 2023; fee-based businesses now majority of net income.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NELNET INC reported the year ended December 31, 2023 results: net income GAAP net income of $91.5 million, EPS $2.45 per share.

Period: the year ended December 31, 2023
Net income: GAAP net income of $91.5 million
EPS: $2.45 per share
Result: reported results

Exact text from the filing

GAAP net income for the year ended December 31, 2023 was $91.5 million, or $2.45 per share

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NELNET INC reported the fourth quarter of 2023 results: net income GAAP net loss of $8.6 million, EPS $0.23 per share.

Period: the fourth quarter of 2023
Net income: GAAP net loss of $8.6 million
EPS: $0.23 per share
Result: reported results

Exact text from the filing

Nelnet (NYSE: NNI) today reported a GAAP net loss of $8.6 million, or $0.23 per share, for the fourth quarter of 2023

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

NELNET INC filing history →

Source: SEC EDGAR

accession 0001258602-24-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.